Indication
Sézary Syndrome
1 clinical trial
2 products
Product
Naloxone HydrochlorideClinical trial
A Double Blind Randomized Vehicle Controlled Crossover Study to Evaluate the Safety and Efficacy of Topical Naloxone Hydrochloride Lotion 0.5% for the Relief of Pruritus in Patients With the MF or SS Forms of Cutaneous T-Cell LymphomaStatus: Terminated, Estimated PCD: 2022-09-01
Product
Placebo